Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Klimek

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Urology and Nephrology|August 8, 1998
Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone diseaseF Kokot, D Klimek, A Wiecek, et al.
Clinical Nephrology|July 15, 1999
Intravenous single dose of erythropoietin (rHuEPO) does not influence plasma leptin concentration in hemodialyzed patients with chronic renal failure (CRF)F Kokot, G Samardzija, D Klimek, et al.
Polskie Archiwum Medycyny Wewnetrznej|January 1, 1996
[Secretion of atrial natriuretic peptide in patients with active renal stone disease]D Klimek, F Kokot, A Wiecek, et al.
Optics Letters|September 11, 2009
Measurement of Raman gain of the S(8) transition of N(2)D Klimek, K Leung, M Oron, et al.
Clinical Nephrology|May 31, 2002
Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patientsM Nowicki, G Szewczyk-Seifert, D Klimek, et al.
Toxicology|September 28, 1984
Effect of toluidines on drug metabolizing enzymes in rat liver, kidney and lungJ Gnojkowski, W Baer-Dubowska, D Klimek, et al.
Polskie Archiwum Medycyny Wewnetrznej|November 1, 1992
[Treatment of anemia with erythropoietin (rhuEPO) in patients with chronic kidney failure who are not yet in need of dialysis therapy]A Wiecek, F Kokot, W Marcinkowski, et al.
Optics Letters|September 11, 2009
Observation of parametric gain suppression in rotational Raman transitions of N(2) and H(2)K Leung, M Oron, D Klimek, et al.
Nephron|August 18, 1999
Does PTH influence leptin concentration in haemodialysed uraemic patients?F Kokot, J Chudek, H Karkoszka, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 1, 1993
[Analysing cause of death in chronically hemodialyzed patients]A Wiecek, P Strzelczyk, D Klimek, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Urology and Nephrology|August 8, 1998
Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone diseaseF Kokot, D Klimek, A Wiecek, et al.
Clinical Nephrology|July 15, 1999
Intravenous single dose of erythropoietin (rHuEPO) does not influence plasma leptin concentration in hemodialyzed patients with chronic renal failure (CRF)F Kokot, G Samardzija, D Klimek, et al.
Polskie Archiwum Medycyny Wewnetrznej|January 1, 1996
[Secretion of atrial natriuretic peptide in patients with active renal stone disease]D Klimek, F Kokot, A Wiecek, et al.
Optics Letters|September 11, 2009
Measurement of Raman gain of the S(8) transition of N(2)D Klimek, K Leung, M Oron, et al.
Clinical Nephrology|May 31, 2002
Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patientsM Nowicki, G Szewczyk-Seifert, D Klimek, et al.
Toxicology|September 28, 1984
Effect of toluidines on drug metabolizing enzymes in rat liver, kidney and lungJ Gnojkowski, W Baer-Dubowska, D Klimek, et al.
Polskie Archiwum Medycyny Wewnetrznej|November 1, 1992
[Treatment of anemia with erythropoietin (rhuEPO) in patients with chronic kidney failure who are not yet in need of dialysis therapy]A Wiecek, F Kokot, W Marcinkowski, et al.
Optics Letters|September 11, 2009
Observation of parametric gain suppression in rotational Raman transitions of N(2) and H(2)K Leung, M Oron, D Klimek, et al.
Nephron|August 18, 1999
Does PTH influence leptin concentration in haemodialysed uraemic patients?F Kokot, J Chudek, H Karkoszka, et al.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|September 1, 1993
[Analysing cause of death in chronically hemodialyzed patients]A Wiecek, P Strzelczyk, D Klimek, et al.
Pageof 3